{"protocolSection":{"identificationModule":{"nctId":"NCT03251521","orgStudyIdInfo":{"id":"38RC17.251"},"organization":{"fullName":"University Hospital, Grenoble","class":"OTHER"},"briefTitle":"Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment","officialTitle":"Evaluation of Pain Intensity in Different Steps of Injection With Botulinum Toxin in the Treatment of Spasticity in Post-stroke Patients","acronym":"DOLOTOX"},"statusModule":{"statusVerifiedDate":"2017-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2013-07","type":"ACTUAL"},"completionDateStruct":{"date":"2013-07","type":"ACTUAL"},"studyFirstSubmitDate":"2017-08-11","studyFirstSubmitQcDate":"2017-08-11","studyFirstPostDateStruct":{"date":"2017-08-16","type":"ACTUAL"},"lastUpdateSubmitDate":"2017-08-11","lastUpdatePostDateStruct":{"date":"2017-08-16","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Grenoble","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The aim of the study was to analyze which step of the procedure of toxin botulinum injection is the most painful between skin break-in, electric stimulation, injection and needle withdrawal.","detailedDescription":"Post-stroke spasticity management by botulinum toxin injections may be limited by pain or discomfort at the injection side.\n\nParticularly tracking by electrostimulation, but also skin puncture, toxin injection or needle withdrawal may be painful.\n\nThe objective of this study is to define an individual injection strategy in order to limit pain."},"conditionsModule":{"conditions":["Post-stroke Spasticity"],"keywords":["pain","spasticity","stroke","injection","botulinum toxin A"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"CASE_ONLY","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":46,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"spasticity post-stroke","description":"pain rating during injection with botulinum toxin The pain intensity was rated verbally on a numeric scale","interventionNames":["Other: pain rating during injection with botulinum toxin"]}],"interventions":[{"type":"OTHER","name":"pain rating during injection with botulinum toxin","description":"The pain intensity was rated verbally on a numeric scale. The pain was rated after each phase of injection","armGroupLabels":["spasticity post-stroke"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Evolution of pain intensity during injection with botulinum toxin","description":"Pain intensity in different steps of the procedure of toxin botulinum injection: skin break-in, electric stimulation, injection and needle withdrawal.","timeFrame":"30 min"}],"secondaryOutcomes":[{"measure":"Hypoesthesia","description":"Semmes Weinstein Monofilament Evaluation","timeFrame":"30 min"},{"measure":"Neuropathic pain","description":"DN4 (Neuropathic pain 4 questions)","timeFrame":"30 min"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* stroke\n* severe upper or lower limb spasticity (Ashworth score â‰¥ 2 for at least one muscle)\n* patients requiring a treatment by botulinum toxin\n* patients refusing analgesia for injections.\n\nExclusion Criteria:\n\n* severe aphasia (severity subscore of the BDAE \\<3)\n* cognitive impairment or psychiatric disease altering the reliability of pain evaluation\n* patient medically unstable.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Consecutive patients were assessed during routine botulinum toxin injection in the day clinic of our department","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Dominic PERENNOU, MD, PhD","affiliation":"University Hospital, Grenoble","role":"PRINCIPAL_INVESTIGATOR"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000009128","term":"Muscle Spasticity"},{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000009135","term":"Muscular Diseases"},{"id":"D000009140","term":"Musculoskeletal Diseases"},{"id":"D000009122","term":"Muscle Hypertonia"},{"id":"D000020879","term":"Neuromuscular Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M11775","name":"Muscle Spasticity","asFound":"Spasticity","relevance":"HIGH"},{"id":"M12756","name":"Pain","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M11782","name":"Muscular Diseases","relevance":"LOW"},{"id":"M11787","name":"Musculoskeletal Diseases","relevance":"LOW"},{"id":"M11769","name":"Muscle Hypertonia","relevance":"LOW"},{"id":"M22309","name":"Neuromuscular Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000001905","term":"Botulinum Toxins"}],"ancestors":[{"id":"D000065087","term":"Acetylcholine Release Inhibitors"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000018678","term":"Cholinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M4873","name":"Botulinum Toxins","asFound":"250","relevance":"HIGH"},{"id":"M250157","name":"abobotulinumtoxinA","relevance":"LOW"},{"id":"M20947","name":"Botulinum Toxins, Type A","relevance":"LOW"},{"id":"M3163","name":"Acetylcholine","relevance":"LOW"},{"id":"M20448","name":"Cholinergic Agents","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"}]}},"hasResults":false}